Hemispherian AS

OSLO, Q8 · Founded 2020 · CIK 0001838780 · Biotech · Private

Epigenetic small molecule cancer therapeutics

hemispherian.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$108K
2 Form D · May 2022
53 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$57,713
Private capital raisedForm D · SEC$50,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1902Blank! The Musical LLC—$550K
1903SEQLL, LLC—$2.5M
1904NANOMEDTRIX LLC——
1905Hemispherian AS—$108K
1906MBF THERAPEUTICS, INC.—$2.0M
1907GRANNUS THERAPEUTICS, INC.—$1.8M
1908Mitera Biosciences Inc.—$1.7M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 8 related persons
  • Zeno AlbisserDirector · Executive Officer
  • Anett DiazDirector
  • Dallas HackDirector
  • Steven PowellDirector
  • Terezia PrikrylovaDirector · Promoter
  • Adam RobertsonDirector · Promoter
  • Masha StrommeDirector
  • Cecilie SverdrupDirector

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.